Physician

Nelson Gustavo Neder Kalil, M.D.

According to 2025 Medicare claims, Nelson Kalil, M.D. (NPI: 1427074707) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is NELSON GUSTAVO NEDER KALIL, M.D. (NPI: 1750569802; TIN: 203529653) and primary practice location at 20852-3803.

Kalil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 119,342 HCPCS/CPT codes, and received $3,754,720 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 418 prescription claims across 98 beneficiaries totaling $998,305 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2022 DME data shows 11 claims. Open Payments data shows 230 records totaling $9,964. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,122,102 and ending at $3,754,720. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $389,112 to $998,305. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	248	187,932	$2,122,102
2016	263	173,235	$2,018,779
2017	271	174,104	$2,799,412
2018	218	146,526	$3,072,394
2019	195	249,086	$3,871,391
2020	197	205,138	$3,929,925
2021	196	180,206	$3,392,827
2022	201	166,495	$3,371,890
2023	224	153,815	$2,703,863
2024	220	119,342	$3,754,720

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	61	339	$389,112
2016	61	390	$258,002
2017	80	532	$585,540
2018	82	512	$745,974
2019	65	369	$587,829
2020	70	328	$542,298
2021	70	299	$578,192
2022	76	331	$795,870
2023	87	341	$1,137,947
2024	98	418	$998,305

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$3,842
2016	N/R	11	$207
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$181
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	61	61	$189
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	626	$108
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	48	145	$55
96372	Injection of drug or substance under skin or into muscle	47	296	$12
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	191	948	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	13	390	$220,761
Eliquis	Apixaban	106	7,410	$139,833
Xarelto	Rivaroxaban	21	1,890	$32,867
Warfarin Sodium	Warfarin Sodium	54	4,082	$777
Atorvastatin Calcium	Atorvastatin Calcium	14	600	$193

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	230	$9,964	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nelson Gustavo Neder Kalil, M.D.?

Tedicare shows public-source Medicare data for Nelson Gustavo Neder Kalil, M.D. (NPI 1427074707), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nelson Gustavo Neder Kalil, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nelson Gustavo Neder Kalil, M.D.?

Nelson Gustavo Neder Kalil, M.D. is linked to NELSON GUSTAVO NEDER KALIL, M.D. (billing NPI 1750569802) in the available physician profile data.

Does Nelson Gustavo Neder Kalil, M.D. have Open Payments data?

Nelson Gustavo Neder Kalil, M.D. has 230 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.